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Abstract
Pharmacological cognitive enhancement (CE) is a topic of increasing public awareness. In the scientific literature on student
use of CE as a study aid for academic performance enhancement, there are high prevalence rates regarding the use of
caffeinated substances (coffee, caffeinated drinks, caffeine tablets) but remarkably lower prevalence rates regarding the use
of illicit/prescription stimulants such as amphetamines or methylphenidate. While the literature considers the reasons and
mechanisms for these different prevalence rates from a theoretical standpoint, it lacks empirical data to account for healthy
students who use both, caffeine and illicit/prescription stimulants, exclusively for the purpose of CE. Therefore, we
extensively interviewed a sample of 18 healthy university students reporting non-medical use of caffeine as well as illicit/
prescription stimulants for the purpose of CE in a face-to-face setting about their opinions regarding differences in general
and morally-relevant differences between caffeine and stimulant use for CE. 44% of all participants answered that there is a
general difference between the use of caffeine and illicit/prescription stimulants for CE, 28% did not differentiate, 28% could
not decide. Furthermore, 39% stated that there is a moral difference, 56% answered that there is no moral difference and
one participant was not able to comment on moral aspects. Participants came to their judgements by applying three
dimensions: medical, ethical and legal. Weighing the medical, ethical and legal aspects corresponded to the students’
individual preferences of substances used for CE. However, their views only partly depicted evidence-based medical aspects
and the ethical issues involved. This result shows the need for well-directed and differentiated information to prevent the
potentially harmful use of illicit or prescription stimulants for CE.
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Introduction
Substance use for pharmacological cognitive enhancement (CE)
by healthy subjects has received increasing attention during the
last decade and is defined as the use of legal (i.e. caffeine) or illicit
substances (i.e. illicit stimulants) as well as prescription drugs (e.g.
methylphenidate, MPH) aiming at the enhancement of various
cognitive functions (e.g. vigilance, concentration, memory) without
medical need [1–5].
According to a recent metaanalysis by Wilens and colleagues,
past-year prevalence rates of stimulant misuse in general ranged
from 5% to 35% among students [6]. Whereas Wilens and
colleagues did not differentiate prevalence rates with regard to the
purpose of use (e.g. getting high, experimentation, concentration,
academic performance enhancement) a more detailed analysis of
the literature revealed that ‘‘concentration’’ and ‘‘study enhance-
ment’’ is one of the most important intentions for stimulant misuse
among students [7,8]. Limited clinical effects for this purpose as
well as potential side effects (e.g. tachycardia, agitation, jitteriness,
gastro-intestinal symptoms) are described in numerous clinical
trials and package inserts [2,9,10].
An online poll of the journal ‘‘Nature’’ depicts a lifetime
prevalence rate of 20% of readers of this journal for stimulants,
modafinil or beta blockers for the purpose of CE [11]. However,
this was a highly biased non-random sample with the lack of
representativeness. A preliminary study of our group has shown
lifetime prevalence rates of 0.8% for prescription stimulants
(MPH) and 2.9% for illicit stimulants (amphetamines (AMPH),
cocaine, ecstasy) exclusively for CE purposes among German high
school students [1].
Caffeine is the most widely-used wake promoting drug in the
world with stimulant effects on the central nervous system (CNS).
A random digit dialling survey in the US among 2,714 participants
(25–74 years) showed that 78% are regular coffee drinkers, and
only 15% had never drunk coffee [12]. Furthermore, a prelim-
inary study of our group showed lifetime prevalence rates
specifically for the purpose of CE in German university students
of 54.9% for coffee, 30.5% for caffeinated/energy drinks and
10.7% for caffeine tablets [13]. In sum, prevalence rates of the
consumption of caffeine exclusively for the purpose of CE are
much higher than prevalence rates of stimulants [1,6,13].
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years there has been a vivid debate concerning CE. In this debate,
scholars have been concerned with aspects such as efficacy, safety,
cognitive liberty, autonomy, authenticity, identity, individuality,
fairness, justice, equality of access, value of human effort, human
nature and the ‘‘medicalization’’ of human life [3,14–18].
Racine and Forlini identified three common paradigms that are
used in order to discuss the non-medical use of prescription
stimulants: the prescription drug abuse paradigm, the CE
paradigm, and the lifestyle use of pharmaceuticals paradigm
[19]. The first of these paradigms makes a clear difference between
the non-medical use of prescription stimulants and the non-
medical use of freely-available substances such as caffeine or
Ginkgo biloba in that it harshly criticizes the non-medical use of
prescription stimulants. In contrast, the other two paradigms, i.e.
the CE paradigm and the lifestyle paradigm, do focus more on the
divergent enhancing effects of the various substances, on the
lifestyle context and on individual choice. In light of the two latter
paradigms they do not draw a strict distinction between the
various substances.
Generally speaking, there are two positions concerning the
question about whether there is a moral difference between
substances: On the one hand are scholars who argue that there is a
moral difference, citing the following as evidence: detrimental
medical aspects on health, negative implications concerning
fairness and justice and issues related to individual identity,
authenticity and medicalization of human life [18,20,21]. On the
other hand are those who point out the similarities between
caffeine and stimulant use. They argue that drug use for CE is in
the same general category and in line with other kinds of
improvements such as education, exercise, or meditation. Scholars
in this camp stress individual autonomy and self-creation
[3,15,22,23].
To our knowledge, no one has conducted an investigation on
the differences between the use of caffeine and stimulants (= illicit
or prescription stimulants such as AMPH or MPH) for CE that is
based on the views of persons who have used both substances for
the purpose of CE.
Methods
Participants
22 university students were recruited by placards on all public
bulletin boards throughout the Campus of the University of
Mainz. As inclusion criteria we searched for healthy students who
had used caffeine and (psycho-) stimulant drugs (AMPH, MPH)
for the purpose of CE. Students with psychiatric disorders (e.g.
attention-deficit hyperactivity disorder (ADHD), schizophrenia)
with current physicians’ prescriptions of psychoactive medication
(e.g. RitalinH) were excluded.
Potential participants were requested to contact us via email or
telephone. Prior to participation, students gave written informed
consent for the interview and sound recording. Participants
received 30,- Euros as compensation for participating. The study
was approved by the local Ethics Committee of the Land-
esa ¨rztekammer Rheinland-Pfalz (Medical Association Rheinland-
Pfalz).
Questionnaire and interviewing procedure
We developed an extensive semi-structured face-to-face inter-
view guideline with consecutively numbered open and closed
questions to gather information about the non-medical use of
stimulants and caffeine for the purpose of CE. ‘‘Stimulants’’ are
meant to be illicit stimulants (AMPH, cocaine, ecstasy) or
prescription stimulants (MPH), but unlike caffeine which was
explained to the participants prior to the interview. After asking
socio-demographic questions (e.g. age, sex, study subject, grades,
etc.) we asked a broad spectrum of questions concerning CE
within the frame of a wider set of interviews among students (data
about characteristics of students using AMPH and/or MPH for
CE compared to a control group and a case study about
characteristics of students using AMPH and MPH have been
already published by Franke and colleagues (2012) and Hildt and
colleagues (2011) [24,25]). The two main questions we used to
elicit participants’ subjective opinions on the type of substance
used for CE (caffeine vs. stimulant drugs) were: ‘‘Is there a
difference between the use of caffeine and stimulants like AMPH
or MPH for CE? Furthermore, is there a moral difference between
the use of caffeine and stimulants like AMPH or MPH for CE?
Please briefly explain why there is or why there is not a
difference’’.
One trained psychologist examined all participants for inclu-
sion/exclusion criteria. The main goal of this pre-interview
procedure was to ensure that all potential participants with
psychiatric disorders (e.g. attention-deficit hyperactivity disorder
(ADHD), schizophrenia) and/or current physicians’ prescriptions
of psychoactive medication were excluded from this study.
Prior to the interviewing process three interviewers were trained
to interview participants following the written semi-structured
interview guideline. Participants were always interviewed by two of
these interviewers in a calm room. One interviewer asked the
questions following the order of the semi-structured questionnaire,
the other noted down participants’ answers in order to add
interview content in case of acoustic problems of sound recording.
Records were transcribed by one third person who was not
involved in the interview procedure.
Coding and analysis
Interviews have been recorded, transcribed verbatim and
analyzed systematically using a qualitative approach based on
inductive category development [26–28].
Transcriptions were analyzed blindly by two independent
raters. For reliability purposes, each rater came up with a set of
three dimensions for the participants’ arguments and justifications.
There were no disagreements between the raters with respect to
the choice of dimensions (medical, ethical and legal). Furthermore,
both raters independently found subcategories for these three
dimensions. Consensus was reached after discussion with regard to
these subcategories in case of initial differences of opinion, thereby
eliminating the need for a third rater.
Results
In spite of eye-catching placards on numerous public bulletin
boards around the entire campus of the University of Mainz
(36,000 registered students), only approximately 30 students
contacted us via email. After having planned the procedure and
having applied the exclusion criteria, 22 interviews were carried
out. Four interviews have not been analysed because of diagnosed
ADHD, Pseudologia fantastica or technical reasons. All partici-
pants (100%, n=18) had experiences using caffeine as well as
prescription and/or illicit stimulants purposeful at least once
exclusively for CE.
Participants were 25.8 years old (mean) and 2/3 of all
participants were male; for further information about the
characteristics of participants, see Table 1.
38.9% (n=8) of all participants had used MPH, 77.8% (n=14)
answered that they had used AMPH, 22.2% (n=4) had used both
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used orally. In contrast, AMPH, which is an illicit drug in
Germany, was administered intranasally by all AMPH users
except one. The frequency of the stimulant use for CE varied
widely; stimulant use ranged from one time only to several times,
and even daily use (for a certain period of time, e.g. some weeks).
Average age of first stimulant use for CE was 20.4 years, average
age of first caffeine use for the purpose of CE was 16.2 years. All
participants had already used caffeine (coffee, caffeinated drinks or
caffeine tablets) for the particular intention of CE. Of these, all
participants except two (88.9%, n=16) had already used coffee at
least once for CE, 55.6% (n=10) caffeinated drinks and 55.6%
(n=10) caffeinated tablets at least once with this particular
intention. Frequency of caffeine use for CE varied widely from
once up to daily (for a certain period of time).
44.4% (n=8) of all interviewed participants stated that there is a
difference in general between the use of caffeine and stimulants for
the purpose of CE. 27.8% (n=5) answered that there is no
difference at all, 27.8% (n=5) were not able to decide whether
there is a difference in general or not.
38.9% (n=7) stated that there is a moral difference, 55.6%
(n=10) answered that there is no moral difference and one
participant was not able to comment on moral aspects at all in
spite of being asked for this explicitly.
After an analysis of interview transcriptions, we identified three
dimensions by which participants argued and justified their points
of view: ethical, medical and legal dimensions, including
subcategories for the ethical and medical dimensions. Table 2
summarizes the main results.
I. Medical Dimension
The medical dimension mentioned by all study participants can
be subdivided into five different categories.
I.1 Efficacy. Nearly all (n=16) participants based their
opinions regarding the difference of substances by considering
the respective substance’s efficacy. The most frequently-stated
medical argument of all participants was that the efficacy of
stimulants is much more pronounced (‘‘Caffeine was much less
intense than stimulants’’). They even tried to quantify the efficacy.
(‘‘Amphetamines have five-fold stronger effects than caffeine, I
would say.’’). On the one hand, participants praised the desirable
efficacy of stimulants, but acknowledged the higher degree of side
effects of stimulants and the better predictability of caffeine effects.
Furthermore, they mentioned the higher degree of changed
metabolism and the longer duration of effects of stimulants.
I.2 Desired effects vs. side effects. Ten participants argued
that there is a notable difference between caffeine and stimulants
regarding desired effects on the one hand and side effects on the
other. The ratio of desired effects and side effects was very
important for forming their opinion. Participants cited physical
and mental side effects as important factors in their decision on
using caffeine or stimulants. In particular, with regard to stimulant
use, they mentioned an impairment to express oneself and ‘‘woolly
thoughts’’, as well as ‘‘modified ways of thinking, talking, behaving
and different types of feelings’’.
However, according to the answers obtained, stimulants had
different effects in different people leading to enhanced or
detrimental cognitive effects depending on the subject’s type of
use of the substance. To be more specific, participants’ answers
revealed more or less pro-cognitive effects regarding the use of
stimulants if they used it only once or a couple of times (during a
monthly or annual time frame). Using stimulants in a high
frequency (e.g. daily, several times per week), the users find them
to have rather detrimental cognitive effects.
Furthermore, participants thought about physical long-term
damage, which was considered to be pronounced in the case of
using stimulants. To some extent, participants argued that
stimulants were more harmful for their body and brain than
caffeine without giving closer explanations for this opinion.
Remarkably, some argued that caffeine’s desirable effects (wake
promoting effects) and side effects (jitteriness) are well-known and
that dosage was very easy to manage (counting cups of coffee)
whereas imprecise dosage of stimulants could be dangerous and
marginal inaccuracy could lead to severe ‘‘over-adrenalized’’/
‘‘over-stimulating’’ side effects. Furthermore, according to them,
caffeine had only wake-promoting effects while stimulants had
‘‘real’’ cognitive enhancing effects (e.g. on concentration). In
addition, participants remarked that some time after intake the
desired effects become transmuted into their opposite. (‘‘One’s
Table 1. Characteristics of participants.
Characteristics
Percentage/Number 100%,
n=18
Gender 66.7% male (n=12)
33.3% female (n=6)
Age (Mean 6 SD) 25.8 years 6 2.88
Completed semesters (Mean 6 SD) 7.35 semester 6 3.79
Department of
- Humanities
- natural sciences
- economics
44.4% (n=8)
33.3% (n=6)
22.2% (n=4)
Data are given as mean 6 standard deviation (SD).
doi:10.1371/journal.pone.0040047.t001
Table 2. Dimensions of arguments and fitting subcategories for the use of illicit/prescription stimulants or caffeine for CE.
I. Medical Dimension II. Ethical Dimension III. Legal Dimension*
Efficacy Self-harm and harm to others
Desired effects vs. side effects Modifications in behaviour and personality
Predictability Accessibility, fairness and justice
Risk of Addiction Individual decision-making and autonomy
Type of effect and mechanism of action Means-end-relation
Social conventions
*Legal dimension cannot be subdivided.
doi:10.1371/journal.pone.0040047.t002
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your inner life.’’).
I.3 Predictability. Three participants differentiated between
caffeine and stimulants in terms of predictability. They argued that
types of effects and efficacy can be anticipated easily in the case of
caffeine whereas the limit of predictability becomes a risk factor
with stimulants. Dose-titration is particularly easy to manage by
counting the number of cups of coffee. One important reason for
the limited predictability of illicit stimulants was the risk of
contamination (‘‘Illicit stimulants can be cut…’’). It was stated that
it was necessary to buy black market stimulants; therefore
predictability of the effect of black market substances was reduced
given the possibility that they could have been cut.
I.4 Risk of Addiction. Five participants cited the risk of
development of addiction regarding psychological dependence.
They differentiated not only between stimulants and caffeine with
a higher risk of addiction with stimulants, but also weighed the risk
of addiction of prescription stimulants (RitalinH) as being lower
than the risk of illicit stimulants.
I.5 Type of effect and mechanism of action. Three
students reported on different ‘‘clinical types’’ of effects. This
ranged from wake promoting effects and ‘‘missing real cognitive
enhancing effects’’ in case of caffeine to ‘‘real concentration
enhancement’’ and ‘‘getting high’’ in the case of stimulants.
A few participants stated ‘‘scientific reasons’’ for differentiation
between stimulants and caffeine and reflected about the influence
on neurotransmitters. One participant even referred to the
‘‘clearance of reservoirs’’ in case of stimulant use without being
able to specify involved neurotransmitters or neurotransmitter
systems. Thus, he associated this clearance of reservoirs with
strong effects directly after the use and feeling leached out and
being excessively tired some hours/one day after having used
stimulants. According to him, this induces re-use and leads to a
vicious cycle (‘‘… have the feeling of being far behind […], you
have the demand for using stimulants again to get some power
again because brain functions are reduced for a certain period of
time […].)’’.
II. Ethical Dimension
Students differed in their opinions with regard to whether there
is a moral difference between the use of caffeine and stimulants for
CE. A typical answer of a participant who considered there to be
no moral difference is: ‘‘Well, morally it doesn’t make any
difference. For me, either way, it’s doping.’’
Among the answers of those participants who stressed that there
is a moral difference, the aspects mentioned can be subdivided in
five different categories.
II.1 Self-harm and harm to others. Ten students stressed
that in their view the misuse of stimulants, in particular of AMPH,
involves a risk of harming one’s body and organism which could
have severely ‘‘negative implications’’. However, sometimes
students stopped without specifying these ‘‘negative implications’’.
By contrast, the participants consider it unlikely that the use of
caffeine is very harmful to one’s health. In this context, one student
explicitly mentioned some kind of obligation to take care of one’s
body, which is needed throughout one’s entire life.
According to another participant, there are no moral problems
with using neuroenhancers as long as the user is able to estimate
the consequences and no other person will be harmed.
II.2 Modifications in behaviour and personality. One of
the participants considered that AMPH use can be problematic
since its effects can include modifications in behaviour and in
personality traits that may continue over several days. By contrast,
he considered short-term problems due to caffeine use, such as
sleeplessness, much more benign.
‘‘When I can’t sleep after spending three or four hours with
coffee that’s one thing, but I know people that change the way they
act, the way they talk and the way they feel, after spending two or
three nights without sleep, they sort of change and that’s why
[stimulants belong in] a different category for me.’’
II.3 Accessibility, fairness and justice. Four students
considered accessibility to be a relevant aspect from a moral point
of view: Whereas caffeine is freely accessible to everybody,
stimulants are not, which implies a lack of equal opportunities.
Only one student explicitly mentioned fairness or justice. He
described considerable advantages that accompany the use of
stimulants (ability to revise and concentrate for a longer period of
time) and considered it unfair to those who are not able to afford
the drugs or who are not aware of them.
II.4 Individual decision-making and autonomy. Aspects
related to individual decision-making and autonomy did not play a
considerable role in the answers. Only one participant directly
stressed individual autonomy, saying that it is up to each person to
decide for herself which substance to take for CE purposes. For
this reason the student opposes any kind of prohibition concerning
drug use and argued for free access to enhancers.
II.5 Means-end-relation. Three participants argued that
enhancers are just a welcome means to help them achieve their
ends and that there is no moral difference whether they use coffee,
energy drinks, RitalinH or whatever else to achieve their ends.
‘‘Well I have a target and I want to reach that target. And to
reach it, I take the substance. I take it to reach my target faster or
more effectively even though maybe it’s just the good feeling that
makes you work a bit more effectively. […] And then it doesn’t
matter what substance it is.’’
The students mentioned ends such as achieving good scores at
university and later obtaining a good job or performing better and
increased productivity.
There were also some more critical opinions, however. One
student said that achieving something without taking enhancing
drugs gives him a better feeling.
Another one argued that the legitimacy of the type of substance
to be used depends on the end a person pursues. He considered it
legitimate for persons in special situations and with a high degree
of responsibility to take stimulants for CE, such as medical doctors,
pilots or those in the military.
II.6 Social conventions. Also the requirement to stick to
social conventions played a role in three of the participants’
answers. They said that the fact that stimulant use is not socially
accepted plays an important role in determining the moral
difference.
III. Legal Dimension
A considerable number of students (n=10) justified their
opinions concerning differences between caffeine and stimulant
use with arguments based on legal aspects. They stated that while
stimulant use is illegal, caffeine is legal. It was mentioned that there
would be a legal inhibition threshold. Illegality was a reason for
keeping the use of stimulants secret: ‘‘The main problem is that
[the use of stimulants] is illegal. Hence, you are treated like a
criminal…’’. The special German Narcotics Act (Beta ¨ubungsmit-
telgesetz, BtMG) was mentioned, too. However, three participants
said clearly that they are not at all worried about law and that
prohibition was not relevant for their decisions regarding whether
to use caffeine or stimulants.
Several participants raised the point of legalization of prescrip-
tion stimulants and illicit drugs. For most of them, the distinction
Caffeine and Psychostimulants for Neuroenhancement
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favour of legalization and argued that if drug use were legal, it
would then be much safer and information would be better.
Others were against legalization of illicit drugs or were undecided
concerning this question.
Discussion
Participants’ answers could be divided in medical, legal and
ethical dimensions easily. The medical and legal dimension played
a crucial role in the participants’ answers to constitute their
decision of using caffeine or stimulants for CE, whereas the ethical
dimension was of limited importance for them.
Differences regarding effect(s) and efficacy of caffeine vs.
stimulants were of notable relevance for the participants.
However, caffeine has at least three established mechanisms of
action: inhibition of cyclic nucleotide phosphodiesterase activity
followed by an accumulation and potentialization of the effects of
3959-cyclic monophosphate (cAMP), blockade of adenosine
receptors; mobilization of intracellular calcium) [2,29–31] which
are quite different from the mechanisms of action of stimulants
(blockade of pre-synaptic norepinephrine and dopaminergic
transporters leading to a reduction/loss of a negative feedback
and thereby leading to an enhanced monoaminergic neurotrans-
mission; this mechanism is strengthened by the vesicular release of
dopamine by AMPH (not MPH)) [2,32–34]. It is very difficult to
agree or disagree with participants’ statements that stimulants
would change metabolism to a greater degree than caffeine. We
can only assert that the mechanisms of action are quite different,
therefore the respective mechanisms of action are not (directly)
comparable. However, the aspect of the different mechanisms of
action leads to the aspect of clinical efficacy, abuse and addiction.
Several participants stated that the (clinical) efficacy of
stimulants is much higher than that of caffeine. However, clinical
trials concerned with the efficacy of stimulants and caffeine that
compare these two substances directly to each other in healthy
subjects show that simple cognitive abilities (vigilance, reaction
time, attentiveness) are increased by caffeine as well as AMPH
with slightly stronger effects of 20 mg D-AMPH compared to
600 mg caffeine [2,35,36]. Furthermore, Wesensten and col-
leagues stated that the duration of the benefits vary in accordance
with the different elimination rates of the substance [36].
However, there are no direct effects on higher cognitive abilities
(e.g. memory) with either substance. Furthermore, AMPH has an
additional mechanism of action compared to MPH leading to
remarkable differences between AMPH and MPH [2]. According
to the literature, stimulants and caffeine seem to be more or less
equally effective regarding simple cognitive abilities, which are not
comparable to complex cognitive abilities mentioned by the
participants of our study (learning, understanding, etc.). The
opinion of stronger effects of stimulants compared to caffeine may
be caused by the expectation of stronger effects in cases of ‘‘illicit’’
drug use compared to legal and broadly-used substances like
coffee. That different legal status may imply stronger (prescription
and illicit stimulants) or weaker (caffeine) effects. In particular the
restricted legal status of stimulants, which requires a specialized
prescription, might lead to an overestimation of their effects and to
an overestimation of one’s own cognitive skills. Beyond that, in
contrast to caffeine, the opinion of stronger effects of AMPH – and
MPH to a smaller extent – could also be explained by indirect
effects of stimulants on motivation and not just cognitive abilities
[10].
Participants often stated a difference regarding the risk of
addiction: students consider the abuse potential and the risk of
addiction of stimulants to be undoubtedly higher than those of
caffeine. Students’ statements reflect what the literature shows.
Prescription stimulants themselves have a certain risk of abuse and
addiction [2,37,38]. Long-standing, these aspects lead to crucial
controversy. Caffeine, however, causes ‘‘only’’ withdrawal symp-
toms in cases of abstinence (after long-term, high-dose use)
[39,40]. Furthermore, illicit stimulants (e.g. illicit AMPH, cocaine,
ecstasy, etc.) are drugs of abuse and/or addiction. In our study,
participants cite a higher abuse and addiction potential with
regard to stimulants as compared to caffeine. It is important to
consider how the participants administered their stimulants: All
AMPH users except one have used stimulants intranasally which
lead to pulsatile dopamine release. Because of this there is a
remarkable higher abuse potential and risk of addiction than in
case of oral use of stimulants.
Interestingly, in their answers, users often did not give
considerable weight to the ethical dimension. This disregard
stands in sharp contrast to interdisciplinary scientific literature in
the CE debate, where ethical aspects of CE such as individual
autonomy, cognitive liberty, authenticity, fairness, justice, pressure
to perform and other social aspects play a crucial role [3,4,14–
18,20].
It seems that the users we interviewed focused on their
individual situation and primarily did not account for conceptual
aspects or broader implications of CE. Most of the users stressed
the usefulness and the potential benefits and harms for themselves
that go along with CE. What primarily mattered to them were
efficacy, effects, and side-effects.
Only one participant explicitly mentioned individual autonomy
as a main argument in favour of CE and in favour of some kind of
liberal regulation concerning CE within society. However, a
related argument on means and ends played a considerable role
for several participants: CE is considered to be a means to better
achieve one’s ends. This argumentation relies on autonomy, too,
albeit in a more indirect way than autonomy-based arguments that
focus on free decision-making and the right to control one’s brain
chemistry. Choosing the means to achieve one’s own goals is an
aspect of autonomy, i.e. of the ideal to create and live one’s life in a
self-determined way. However, among the students interviewed,
there is some lack of reflection on the adequateness of the means
used. For some of the students, the end that they pursued even
seemed to directly justify the means used.
It seems that most of the students we interviewed did not
consider arguments that can be considered genuinely moral
arguments, i.e. arguments that have to do with rights and
obligations towards others. In fact, only one of the students we
interviewed mentioned aspects related to fairness or justice, and
only one student mentioned possible harm to others.
Genuine moral arguments would require a broader view which
takes the interpersonal and social context into consideration.
Instead, at least in their answers to the interview question, the
students primarily focused on their individual situation and
reflected on how to best achieve their ends. It seems that they
did not thoroughly reflect on the context of their actions.
In the interviews, we did not give a definition of ‘‘moral’’ or
‘‘ethical’’, so perhaps participants each had different notions of
moral differences with regard to caffeine and stimulant use.
Clearly, the answers we received represent folk morality, the views
of those directly involved.
In contrast to this limited awareness of ethical issues regarding
CE, the participants’ argumentation focused heavily on the
illegality of stimulant use. Students emphasized the fact that using
stimulants in a non-medical context is something illegal, and this
fact mattered to them. In Germany, ready-made AMPH-drugs
Caffeine and Psychostimulants for Neuroenhancement
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RitalinH) falls under the German Narcotics Act (BtMG). We found
that with regard to medical law, participants were well-informed.
When asked for moral reasons or moral arguments, a
considerable number of students just mentioned illegality. For
some, illegality is an important argument against the use of
stimulants for CE purposes, while others argue for legalization of
stimulant use for CE. It seems that illegality of stimulant use serves
as a decisive argument that ends any further discussion. Moral
arguments may play such a limited role given the illegality of
stimulants.
Participants often began arguing amongst themselves about
justifications for the use of caffeine or stimulants using divergent
moral arguments, then came to the point of legal aspects and then
promptly ended their discussion directly after naming legal
aspects. Others named legal arguments earlier in their argumen-
tation, then stopped and had to be asked by the interviewers to
continue with their explanations. It seemed that the legal aspect
was the ‘‘hardest’’ and most clear argument for them. The moral
arguments seem to have been left to law-makers without
recognizing the differences between those participants calling for
liberalisation and those who did not.
The fact that illegality was so important in the users’ evaluation
of CE sheds some interesting light on calls for liberal guidelines or
liberal policy approaches concerning CE such as the one put
forward by Greely and colleagues [15]. Based on the results
presented here, one may expect that liberalization would lead
people to assume that there are no further relevant ethical issues
with regard to CE.
After having discussed different aspects of students’ answers
given in interviews, let us now reflect on the status of the results
obtained: To what extent are consumers’ opinions regarding
medical, legal and moral aspects of CE relevant?
The students told us just those aspects or ideas that came to
their mind during the limited period of the interviews. This does
not mean that their answers and aspects mentioned were the only
ones they had ever considered regarding CE. Furthermore, we do
not assume that they always responded candidly. To a certain
degree, one might expect that answers are influenced by social
expectations in interview situations. On the other hand, however,
the atmosphere during the interviews was casual and we pointed
out the anonymity of participants’ responses so that we might
reasonably expect to have obtained their genuine views.
It is important to stress that the interview responses do not tell
us whether there is a moral difference between the use of
stimulants or of caffeine. They do not give us any ‘‘objective’’ data
concerning efficacy, effects and side effects either. Instead, they
give us some ideas about the aspects that matter to the persons
involved, of how they see the situation. This perspective helps to
establish an empirically-informed basis for the discussion of
medical, social and ethical implications of CE. Such an
empirically-informed basis is an important presupposition for
any kind of future policy recommendation or regulation concern-
ing CE.
Beyond that, we have to admit that our findings have to be
carefully interpreted and generalized. Interviews were carried out
among a group of only 18 students who replied to placards on
bulletin boards around the University campus which means that
there is a selection bias. Furthermore, 2/3 of all interviewed
participants are male and the age of the participants is relatively
high for a university sample (mean: 25.8 years). Although these
aspects limit the power of this study, we gained an initial insight
about the reasons for the choice of the type of substance which is
used for CE.
Conclusion
Students using stimulants and caffeine for CE value medical,
legal and ethical aspects to different extents. Less than half of the
students see relevant differences between both substances. Medical
and legal aspects play a major role, ethical reasons a minor role
which seems to be overestimated in the literature. Weighing the
medical, ethical and legal aspects corresponded to the individual
preferences of substances used for CE. However, their views only
partly depicted evidence-based medical aspects and the ethical
issues involved. This result shows the need for well-directed and
differentiated information to prevent the potentially harmful use of
stimulants for CE.
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